**Core Concept**
Pneumococcal meningitis is a severe and potentially life-threatening infection caused by Streptococcus pneumoniae. Effective empirical treatment is crucial to prevent complications and reduce mortality. The choice of antibiotics is guided by the pathophysiology of bacterial meningitis, which involves the spread of bacteria through the cerebrospinal fluid (CSF) and the blood-brain barrier.

**Why the Correct Answer is Right**
The empirical treatment of pneumococcal meningitis typically involves a combination of antibiotics that can penetrate into the CSF and reach effective concentrations against S. pneumoniae. **Ceftriaxone**, a third-generation cephalosporin, is a commonly used antibiotic for empirical treatment due to its ability to cross the blood-brain barrier and achieve high concentrations in the CSF. Additionally, **vancomycin**, a glycopeptide antibiotic, is often added to the regimen to cover for possible penicillin-resistant strains of S. pneumoniae.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not include a third-generation cephalosporin, which is essential for effective treatment of pneumococcal meningitis.
**Option B:** This option is incorrect because it does not include vancomycin, which is necessary to cover for possible penicillin-resistant strains of S. pneumoniae.

**Clinical Pearl / High-Yield Fact**
In cases of suspected bacterial meningitis, empirical treatment should be initiated promptly without waiting for CSF culture results, as delays can lead to increased mortality and morbidity. The choice of antibiotics should be guided by local antibiotic resistance patterns and the suspected causative organism.

**Correct Answer:** C. Ceftriaxone and Vancomycin